While the function of these autoantibodies against galectin-3 remains to be resolved, they were not detected in PSC patients [176], indicating that galectin-3 autoantibodies are not involved in PSC-related disease pathology. The gene discussed is LGALS3; the disease is pancreatic serous cystadenoma.